{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:31:31Z","timestamp":1788715891087,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bioorg.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T03:13:20Z","timestamp":1515640400000},"page":"106-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents"],"prefix":"10.1016","volume":"77","author":[{"given":"Garima","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gousia","family":"Chashoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-1577","authenticated-orcid":false,"given":"Mohemmed Faraz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israr","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mymoona","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mumtaz","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shaquiquzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.01.007_b0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejmech.2017.04.029","article-title":"Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide","volume":"135","author":"Ugwu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0010","unstructured":"World Malaria Report, World Health Organization, Geneva, 2016, pp. 39\u201351."},{"key":"10.1016\/j.bioorg.2018.01.007_b0015","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1021\/jm500066b","article-title":"Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransderases directed by ligand efficiency dependent lipophilicity (LELP)","volume":"57","author":"Rackham","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejmech.2016.07.055","article-title":"4,5-Dihydrooxazole-pyrazoline hybrids: synthesis and their evaluation as potential antimalarial agents","volume":"123","author":"Pandey","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2017.04.022","article-title":"Guanylthiourea derivatives as potential antimalarial agents: synthesis, in vivo and molecular modelling studies","volume":"135","author":"Bhagat","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0030","article-title":"Design, synthesis and evaluation of 2-(4-(substituted benzoyl)-1,4-diazepan-1-yl)-N-phenylacetamide derivatives as a new class of falcipain-2 inhibitors","author":"Mahesh","year":"2014","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0035","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.bmc.2013.04.047","article-title":"Falcipain-2 inhibition by suramin and suramin analogues","volume":"21","author":"Marques","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0040","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1016\/j.bmc.2009.08.013","article-title":"Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors","volume":"17","author":"Micale","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molbiopara.2013.01.002","article-title":"Substrate specificity studies of the cysteine peptidases falcipain-2 and falcipain-3 from plasmodium falciparum and demonstration of their kininogenase activity","volume":"187","author":"Cotrin","year":"2013","journal-title":"Mol. Biochem. Parasit."},{"key":"10.1016\/j.bioorg.2018.01.007_b0050","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.ejmech.2011.02.061","article-title":"Design and synthesis of protein-protein interaction mimics as Plasmodium falciparum cysteine protease, falcipain-2 inhibitors","volume":"46","author":"Rizzi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0055","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1021\/acs.bioconjchem.6b00683","article-title":"Dual stimuli-activable oxidative stress amplifying agent as a hybrid anticancer prodrug","volume":"28","author":"Han","year":"2017","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0060","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1021\/acs.jmedchem.6b00468","article-title":"Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles","volume":"59","author":"Nieddu","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0065","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1021\/acs.jmedchem.5b00035","article-title":"Methhyl 3-((6-Methoxy-1,4,-dihydroindeno[1,2-c]pyrazol-3-yl)benzoate (GN39482) as a tubulin polymerization inhibitor identified by MorphoBase and ChemProteoBase profiling methods","volume":"58","author":"Minegishi","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejmech.2017.05.017","article-title":"Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: synthesis, characterization and anticancer activity","volume":"136","author":"Coskun","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0075","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ejmech.2014.12.013","article-title":"Novel pyrazle-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity","volume":"90","author":"Shi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ejmech.2016.10.052","article-title":"Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents","volume":"127","author":"Chaves","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejmech.2016.04.077","article-title":"The therapeutic voyage of pyrazole and its analogs: a review","volume":"120","author":"Khan","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0090","doi-asserted-by":"crossref","first-page":"S503","DOI":"10.1016\/j.arabjc.2012.10.010","article-title":"Synthesis, characterization and antimicrobial activity of 1,3,4-oxadiazole baring 1H-benzimidazole derivatives","volume":"10","author":"Shaharyar","year":"2017","journal-title":"Arabian J. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bioorg.2016.09.005","article-title":"Novel 1,3,4-oxadiazole\/oxime hybrids: synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities","volume":"69","author":"Abd-Ellah","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejmech.2016.11.041","article-title":"S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents","volume":"126","author":"Karabanovich","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/14756366.2014.958081","article-title":"Novel pyrazole-pyrazoline hybids endowed with thioamide as antimalarial agents: their synthesis and 3D-QSAR studies","volume":"30","author":"Marella","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ardp.201100078","article-title":"Synthesis and biological evaluation of some pyrazole derivatives as antimalarial agents","volume":"345","author":"Bekhit","year":"2012","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.bioorg.2018.01.007_b0115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jchromb.2016.09.012","article-title":"Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor, encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O-desmethyl metabolites of erlotinib and gefitinib in human plasma","volume":"1033\u20131034","author":"Sparidans","year":"2016","journal-title":"J. Chrom. B"},{"key":"10.1016\/j.bioorg.2018.01.007_b0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lungcan.2017.05.018","article-title":"Identification of a novel T1151K ALK mutation in a patient with ALK-rearranged NSCLC with prior exposure to crizotinib and ceritinib","volume":"110","author":"Zhu","year":"2017","journal-title":"Lung Cancer."},{"key":"10.1016\/j.bioorg.2018.01.007_b0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/14756360601114569","article-title":"Synthesis and antimalarial activity of novel chiral and achiral benzenesulonamides bearing 1,3,4-oxadiazole moieties","volume":"22","author":"Zareef","year":"2007","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0130","doi-asserted-by":"crossref","first-page":"41532","DOI":"10.1039\/C6RA01349J","article-title":"Design, synthesis, and characterization of a fluoro substituted novel pyrazole nucleus clubbed with 1,3,4-oxadiazole scaffolds and their biological applications","volume":"6","author":"Karad","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2018.01.007_b0135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejmech.2017.03.039","article-title":"Novel 2-benzylthio-5-(1,3,4-oxadizol-2-yl)benzenesulfnamides with anticancer activity: synthesis, QSAR study, and metabolic stability","volume":"132","author":"Slawinski","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jsps.2016.07.004","article-title":"Synthesis, characterization and biological evaluation of novel 2,5 substituted-1,3,4-oxadiazole derivatives","volume":"25","author":"Selvaraj","year":"2017","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2018.01.007_b0145","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ejmech.2012.05.022","article-title":"Novel cinnamic acid\/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: towards the development of potential dual action antimalarials","volume":"54","author":"Perez","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0150","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.bmc.2011.12.057","article-title":"Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents","volume":"20","author":"Yang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejmech.2015.01.040","article-title":"Synthesis, in vitro and in vivo antitumor activity of scopoletin-cinnamic acid hybrids","volume":"93","author":"Li","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0160","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ejmech.2014.08.040","article-title":"Synthesis and biological evaluation of hydroxycinnamic acid hydrazide derivatives as inducer of caspase-3","volume":"85","author":"Wu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0165","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejmech.2016.08.062","article-title":"Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids","volume":"124","author":"Kraljevic","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejmech.2017.03.007","article-title":"N-piperonyl substitution on aminoquinoline-pyrimidine hybrids: effect on the antiplasmodial activity","volume":"131","author":"Kholiya","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0175","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1021\/jo00339a023","article-title":"Applications of the Vilsmeier reaction. 13. Vilsmeier approach to polycyclic aromatic hydrocarbons","volume":"46","author":"Reddy","year":"1981","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0180","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1590\/S0100-40422006000500035","article-title":"On the application of knoevenagel condensation for the synthesis of benzylidene benzothiazine compounds and structural study","volume":"29","author":"Souza","year":"2006","journal-title":"Quim Nova"},{"key":"10.1016\/j.bioorg.2018.01.007_b0185","doi-asserted-by":"crossref","unstructured":"K.E. Kolb, K.W. Field, P.F. Schatz, One step synthesis of cinnamic acids using malonic acid: the Verley-Doebner modification of the Knoevenagel condensation, J. Chem. Edu. A 304.","DOI":"10.1021\/ed067pA304"},{"key":"10.1016\/j.bioorg.2018.01.007_b0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bioorg.2017.05.007","article-title":"Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives","volume":"73","author":"Naim","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0195","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1155\/2009\/247209","article-title":"Synthesis, spectral and microbial studies of some novel Schiff base derivatives of 4-Methylpyridin-2-amine","volume":"6","author":"Vora","year":"2009","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0200","doi-asserted-by":"crossref","first-page":"9046","DOI":"10.3390\/molecules15129046","article-title":"Synthesis and antiviral activity of 5-(4-Chlorophenyl)-1,3,4-thiadiazole sulfonamides","volume":"15","author":"Chen","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2018.01.007_b0205","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/jm00378a007","article-title":"Synthesis of 5-Aryl-2H-tetrazoles, 5-Aryl-2H-tetrazole-2-acetic acids, and [(4-Phenyl-5-aryl-4H-1,2,4-triazol-3-yl)thio]acetic acids as possible superoxide scavengers and anti-inflammatory agents","volume":"27","author":"Maxwell","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0210","doi-asserted-by":"crossref","first-page":"S488","DOI":"10.1016\/j.jscs.2013.02.006","article-title":"Synthesis of new N-(5-chloro-2-methoxyphenyl)-4-(5-substituted-1,3,4-oxadiazol-2-ylthio)butanamide derivatives as suitable lipoxygenase inhibitors","volume":"20","author":"Rehman","year":"2016","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.bioorg.2018.01.007_b0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"110","key":"10.1016\/j.bioorg.2018.01.007_b0220","first-page":"39","article-title":"Sulforhodamine B assay and chemosensitivity","volume":"2005","author":"Voigt","year":"2005","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.bioorg.2018.01.007_b0225","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2018.01.007_b0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206817308465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206817308465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:44:58Z","timestamp":1758613498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206817308465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":46,"alternative-id":["S0045206817308465"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.01.007","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}